Effects of recombinant adenovirus hepatocyte growth factor gene on myocardial remodeling in spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 18, Issue 5, 2013, Pages 476-480

  Hu, Ze Ping ^a   Bao, Yong ^a   Chen, Da Nian ^a   Cheng, Yuan ^a   Song, Bing ^a   Liu, Min ^a   Li, Dayuan ^b   Wang, Bang Ning ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

gene expression; gene therapy; hemodynamic.; HGF; myocardial remodeling

Indexed keywords

COLLAGEN TYPE 1; RECOMBINANT SCATTER FACTOR; SCATTER FACTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEMODYNAMIC PARAMETERS; HISTOLOGY; HYPERTENSION; IMAGE ANALYSIS; MYOCARDIAL REMODELING; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; WESTERN BLOTTING;

GENE EXPRESSION; GENE THERAPY; HEMODYNAMIC.; HGF; MYOCARDIAL REMODELING;

ADENOVIRIDAE; ANIMALS; FIBROSIS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HEART FAILURE; HEPATOCYTE GROWTH FACTOR; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MYOCARDIUM; RATS; RATS, INBRED SHR; RATS, INBRED WKY; UP-REGULATION;

EID: 84882253711     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248413490832     Document Type: Article

References (24)

1. Polizio AH, Balestrasse KB, Yannarelli GG, et al. Angiotensin II regulates cardiac hypertrophy via oxidative stress but not antioxidant enzyme activities in experimental renovascular hypertension. Hypertens Res. 2008 ; 31 (2). 325-334
2. Ravingerová T, Bernátová I, Matejíková J, et al. Impaired cardiac ischemic tolerance in spontaneously hypertensive rats is attenuated by adaptation to chronic and acute stress. Exp Clin Cardiol. 2011 ; 16 (3). e23 - e29
3. Kai H, Kudo H, Takayama N, Yasuoka S, Kajimoto H, Imaizumi T. Large blood pressure variability and hypertensive cardiac remodeling - role of cardiac inflammation. Circ J. 2009 ; 73 (12). 2198-2203
4. Yip GW, Fung JW, Tan YT, Sanderson JE. Hypertension and heart failure: a dysfunction of systole, diastole or both?. J Hum Hypertens. 2009 ; 23 (5). 295-306
5. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991 ; 251 (4995). 802-804
6. Hahn W, Pyun WB, Kim DS, et al. Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model. J Gene Med. 2011 ; 13 (10). 549-555
7. Banquet S, Gomez E, Nicol L, et al. Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation. 2011 ; 124 (9). 1059-1069
8. Guo Y, He J, Wu J, et al. Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis. Arch Med Res. 2008 ; 39 (2). 179-188
9. Yan L, Zhu TB, Wang LS, et al. Inhibitory effect of hepatocyte growth factor on cardiomyocytes apoptosis is partly related to reduced calcium sensing receptor expression during a model of simulated ischemia/reperfusion. Mol Biol Rep. 2011 ; 38 (4). 2695-2701
10. Poppe A, Golsong P, Blumenthal B, et al. Hepatocyte growth factor-transfected skeletal myoblasts to limit the development of postinfarction heart failure. Artif Organs. 2012 ; 36 (3). 238-246
11. Yang ZJ, Chen B, Sheng Z, et al. Improvement of heart function in postinfarct heart failure swine models after hepatocyte growth factor gene transfer: comparison of low-, medium- and high-dose groups. Mol Biol Rep. 2010 ; 37 (4). 2075-2081
12. Nakamura T, Matsumoto K, Mizuno S, Sawa Y, Matsuda H, Nakamura T. Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am J Physiol Heart Circ Physiol. 2005 ; 288 (5). H2131 - H2139
13. Ahmet I, Sawa Y, Iwata K, Matsuda H. Gene transfection of hepatocyte growth factor attenuates cardiac remodeling in the canine heart: a novel gene therapy for cardiomyopathy. J Thorac Cardiovasc Surg. 2002 ; 124 (5). 957-963
14. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment. Circulation. 2002 ; 105 (12). 1503-1508
15. Behr TM, Willette RN, Coatney RW, et al. Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease. J Hypertens. 2004 ; 22 (3). 583-592
16. Taniyama Y, Morishita R, Nakagami H, et al. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation. 2000 ; 102 (2). 246-252
17. Chen XH, Minatoguchi S, Kosai K, et al. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. J Card Fail. 2007 ; 13 (10). 874-883
18. Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart. 2000 ; 84 (5). 476-482
19. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999 ; 79 (1). 215-262
20. Lombardi R, Betocchi S, Cacace A, Losi MA, Chiariello M. Myocardial interstitial fibrosis and diastolic dysfunction in hypertrophic cardiomyopathy. Ital Heart J Suppl. 2003 ; 4 (8). 645-650
21. Bishop JE, Laurent GJ. Collagen turnover and its regulation in the normal and hypertrophying heart. Eur Heart J. 1995 ; 16 (suppl C). 38-44
22. Mizuno S, Matsumoto K, Nakamura T. HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease. Front Biosci. 2008 ; 13: 7072-7086
23. Shirakawa Y, Sawa Y, Takewa Y, et al. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices. J Thorac Cardiovasc Surg. 2005 ; 130 (3). 624-632
24. Rastogi S, Guerrero M, Wang M, et al. Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs. Am J Physiol Heart Circ Physiol. 2011 ; 300 (4). H1501 - H1509